NRX Pharmaceuticals
NRXP
NRXP
33 hedge funds and large institutions have $3.44M invested in NRX Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
0.15% less ownership
Funds ownership: 0.61% → 0.46% (-0.15%)
Holders
33
Holding in Top 10
–
Calls
$358K
Puts
$51K
Top Buyers
| 1 | +$65K | |
| 2 | +$64.4K | |
| 3 | +$48.5K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$39.4K |
| 5 |
AWM
AE Wealth Management
Topeka,
Kansas
|
+$32.8K |
Top Sellers
| 1 | -$306K | |
| 2 | -$74.5K | |
| 3 | -$37K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$17K |
| 5 |
Goldman Sachs
New York
|
-$16K |